Literature DB >> 25001342

Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study.

Elçin Sehitoğlu1, Filiz Cavuş, Canan Ulusoy, Melike Küçükerden, Arda Orçen, Deniz Akbaş-Demir, Arzu Coban, Burçak Vural, Erdem Tüzün, Recai Türkoğlu.   

Abstract

OBJECTIVE: To identify an antibody biomarker for prediction of conversion from radiologically isolated syndrome (RIS) to relapsing remitting multiple sclerosis (RRMS).
METHODS: Sera of 13 RIS patients were screened by a protein macroarray derived from human fetal brain cDNA library.
RESULTS: Sequencing of a clone with the highest signal intensity revealed sorcin as a potential target autoantigen in RIS patients. ELISA studies showed high-titer sorcin-antibodies in 3 of 4 RIS patients who converted to RRMS in a 5-year follow-up period and 13 of 23 control RRMS patients.
CONCLUSION: The value of sorcin antibody as a predictor of conversion from RIS to RRMS requires to be tested in larger prospective studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25001342     DOI: 10.1007/s00011-014-0754-0

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  9 in total

1.  Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.

Authors:  D T Okuda; E M Mowry; A Beheshtian; E Waubant; S E Baranzini; D S Goodin; S L Hauser; D Pelletier
Journal:  Neurology       Date:  2008-12-10       Impact factor: 9.910

Review 2.  Asymptomatic MS.

Authors:  Aksel Siva
Journal:  Clin Neurol Neurosurg       Date:  2013-12       Impact factor: 1.876

3.  Ultrastructural localization of sorcin, a 22 kDa calcium binding protein, in the rat caudate-putamen nucleus: association with ryanodine receptors and intracellular calcium release.

Authors:  V M Pickel; C L Clarke; M B Meyers
Journal:  J Comp Neurol       Date:  1997-10-06       Impact factor: 3.215

4.  Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet's disease.

Authors:  Burçak Vural; Elif Uğurel; Erdem Tüzün; Murat Kürtüncü; Luigi Zuliani; Filiz Cavuş; Sema Içöz; Ece Erdağ; Ahmet Gül; Ali O Güre; Angela Vincent; Uğur Ozbek; Mefkure Eraksoy; Gülşen Akman-Demir
Journal:  J Neuroimmunol       Date:  2011-08-27       Impact factor: 3.478

5.  Potassium channel KIR4.1 as an immune target in multiple sclerosis.

Authors:  Rajneesh Srivastava; Muhammad Aslam; Sudhakar Reddy Kalluri; Lucas Schirmer; Dorothea Buck; Björn Tackenberg; Veit Rothhammer; Andrew Chan; Ralf Gold; Achim Berthele; Jeffrey L Bennett; Thomas Korn; Bernhard Hemmer
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

6.  Nicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system.

Authors:  Chiara Cordiglieri; Francesca Odoardi; Bo Zhang; Merle Nebel; Naoto Kawakami; Wolfgang E F Klinkert; Dimtri Lodygin; Fred Lühder; Esther Breunig; Detlev Schild; Vijay Kumar Ulaganathan; Klaus Dornmair; Werner Dammermann; Barry V L Potter; Andreas H Guse; Alexander Flügel
Journal:  Brain       Date:  2010-06-02       Impact factor: 13.501

Review 7.  B cells and antibodies in multiple sclerosis pathogenesis and therapy.

Authors:  Markus Krumbholz; Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

Review 8.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

9.  Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes.

Authors:  A Ruiz; C Matute; E Alberdi
Journal:  Cell Death Dis       Date:  2010-07-15       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.